Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | 0.6 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | n/a | (2.32) | (2.80)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (5.25) | (6.43)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (5.61) | (6.88)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (5.10) | (0.06)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | n/a | n/a | (0.91)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Replacement Half Year Report | 30-Sep-2025 | 13:09 | RNS |
Half-year Report | 30-Sep-2025 | 07:00 | RNS |
Publication of 2024 Annual Report | 26-Jun-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.15p |
Closing Price Change | 0.000p |
% Change | 0.00 % |
52 Week High | 1.15 |
52 Week Low | 1.15 |
Volume | 0 |
Shares Issued | 88.46m |
Market Cap | £1.02m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
You are here: research